You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 9, September 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy

J. Ghika and J. Bogousslavsky
Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

OBJECTIVE: To examine the history of hypertension (HT) in patients with parkinsonism (PS) of various causes. PATIENTS: Nine hundred twenty-three patients with PS listed in a citywide movement disorders registry. Hypertension was defined as blood pressure above 150/90 mm Hg on at least 2 occasions or a history of antihypertensive medication use. RESULTS: Overall, 184 patients (20.6%) had a history of HT. Fifty-three (16.6%) of 320 patients with levodopa-responsive parkinsonism (PD) had a history of HT; similar prevalence of presymptomatic HT was seen for PS and dementia (22/165 [13.3%]), including probable diffuse Lewy body disease and multiple system atrophy of the nigrostriatal degenerative type (33/171 [19.3%]). Olivopontocerebellar atrophy (7/40 [18%]), corticobasal ganglionic degeneration (5/15 [33.3%]), drug-induced PS (9/38 [23.1%]), and the predominantly tremulous forms of Parkinson disease (17/43 [39.5%]) showed a higher prevalence of HT. Patients with familial PS (n = 36), early-onset PD (n = 14), multiple system atrophy of the Shy-Drager type (n = 11), and postencephalitic PS (n = 6) had no history of HT. In 100 patients with PS of various rare etiologies, a history of HT was seen in less than 5%. The highest prevalence of HT was seen in patients with clinically diagnosed progressive supranuclear palsy (n = 42), of whom 34 (81.0%) had a history of HT. CONCLUSIONS: A presymptomatic history of HT is a major feature in the clinical history of progressive supranuclear palsy and may be a diagnostic criterion. Its significance is unknown, but adrenergic nuclei of the brainstem are severely affected, and HT may be the first symptom arising from involvement of these nuclei. This could also explain the features of small vessel disease seen on computed tomography or magnetic resonance imaging in 50% of our patients, as in previous reports.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tau genotype: No effect on onset, symptom severity, or survival in progressive supranuclear palsy
Litvan et al.
Neurology 2001;57:138-140.
ABSTRACT | FULL TEXT  

Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy
Kimber et al.
Brain 2000;123:1422-1430.
ABSTRACT | FULL TEXT  

Clinical Correlates of Vascular Parkinsonism
Winikates and Jankovic
Arch Neurol 1999;56:98-102.
ABSTRACT | FULL TEXT  

Parkinson's Disease- First of Two Parts
Lang and Lozano
NEJM 1998;339:1044-1053.
FULL TEXT  

Presymptomatic Hypertension in Progressive Supranuclear Palsy
Fabbrini et al.
Arch Neurol 1998;55:1153-1155.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.